ITK and JAK3
Assets acting on this target.
- Class
- dual ITK/JAK3 inhibitor (oral small molecule)
- Pathway
- ITK inhibition blocks TCR-driven T-cell activation/differentiation; JAK3 inhibition blocks gamma-chain cytokine receptor signaling
Related mechanisms